Inna Tulaeva

13PUBLICATIONS
68CO-AUTHORS
Major global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsNon-genetically modified uses of biotechnologyInnate immunityAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 26, 2026
Towards Sensitization Profiling for Allergy Prevention in Russia: A Systematic Review.

|Aug 28, 2025
VVX001 Induces preS-Specific Antibodies Reacting to Common HBV Genotypes in Hepatitis B Virus (HBV) Carrier Mice.

Inna Tulaeva, Maryline Bourgine, Carolin Cornelius-Nikl

|Oct 26, 2024
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV Vaccines.

Inna Tulaeva, Felix Lehmann, Nora Goldmann

|Jul 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.

Bernhard Kratzer, Pia Gattinger, Doris Trapin

|Oct 19, 2023
Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.

Musa Khaitov, Igor Shilovskiy, Rudolf Valenta

|Sep 13, 2023
Natural human Bet v 1-specific IgG antibodies recognize non-conformational epitopes whereas IgE reacts with conformational epitopes.

Georgii Brazhnikov, Evgenii Smolnikov, Alla Litovkina

Pageof 3

Frequent Collaborators

10 joint publications

Rudolf Valenta

8 joint publications

Winfried F Pickl

8 joint publications

Pia Gattinger

7 joint publications

Bernhard Kratzer